The expression of GPAM (glycerol-3-phosphate acyltransferase), a key enzyme in lipid biosynthesis, is increased in breast and other cancers and highly correlated with clinicopathological parameters [45]; its inhibition reduces ovarian cancer cell migration and the growth of tumor xenograft mouse models [46]. Here, GPAT3 is linked to ovarian cancer.